YI Jinling, Tubikezi·YIBILI, Gulihumaer·AINIWAER, LA Xiaolin. Effect of TAM family receptor tyrosine kinases on signaling pathway of mammalian target of rapamycin in patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 7-12, 16. DOI: 10.7619/jcmp.20223087
Citation: YI Jinling, Tubikezi·YIBILI, Gulihumaer·AINIWAER, LA Xiaolin. Effect of TAM family receptor tyrosine kinases on signaling pathway of mammalian target of rapamycin in patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 7-12, 16. DOI: 10.7619/jcmp.20223087

Effect of TAM family receptor tyrosine kinases on signaling pathway of mammalian target of rapamycin in patients with endometriosis

More Information
  • Received Date: October 10, 2022
  • Available Online: December 14, 2022
  • Objective 

    To explore the effect of TAM family receptor tyrosine kinases (Axl) on signaling pathway of mammalian target of rapamycin (mTOR) in patients with endometriosis (EMS).

    Methods 

    The eutopic and ectopic endometrium tissues of 5 patients with ovarian EMS were collected, and 5 normal endometrium tissues were selected as controls. Human ectopic endometrial stromal cells (HEcESCs), human eutopic endometrial stromal cells (HEuESCs) and human normal endometrial stromal cells (HEnESCs) were isolated and cultured for immunohistochemical identification, and the mechanism of regulating PI3K/AKT signal pathway by targeting upstream Axl and mTOR kinase at cell level to affect apoptosis of human embryonic stem cells (HESCs) was analyzed. Real-time fluorescent quantitative polymerase chain reaction (qRT-PCR) was used to verify the differences of Axl, mTOR mRNA expressions in HEcESCs, HEuESCs and HEnESCs; at the cell level, siRNA transfection was used to regulate Axl targets, rapamycin was used to regulate mTOR targets, and Western blotting and qRT-PCR were used to detect the differences in the expressions of Axl, mTOR, phosphorylated mTOR (p-mTOR) and CyclinD1.

    Results 

    Compared with HEnESCs, the expression levels of Axl mRNA and mTOR mRNA in HEuESCs and HEcESCs showed significant difference (P < 0.05); compared with the blank control group, the expression levels of Axl mRNA and CyclinD1 mRNA in rapamycin treated group and Axl-siRNA treated group showed significant difference (P < 0.05); compared with the rapamycin treated group, the Axl mRNA expression level in the Axl-siRNA treated group showed significant difference (P < 0.05); compared with the negative control group, the expression levels of Axl mRNA and CyclinD1 mRNA in the rapamycin treated group showed significant difference (P < 0.05); compared with the negative control group, the expressions of Axl mRNA and CyclinD1 mRNA in the Axl-siRNA treated group showed significant difference (P < 0.05); compared with the blank control group, the relative expression level of mTOR mRNA in the rapamycin treated group showed significant difference (P < 0.05). There was no significant difference in mTOR protein expression among the four groups (P>0.05); compared with the blank control group, the expressions of p-mTOR and CyclinD1 protein in the rapamycin treated group and Axl-siRNA treated group showed significant difference (P < 0.05), and the difference compared with the negative control group was also statistically significant (P < 0.05).

    Conclusion 

    Regulation of Axl and mTOR can promote apoptosis of HEcESCs, and Axl participates in the occurrence of EMS by mediating mTOR signal pathway.

  • [1]
    SAUNDERS P T K, HORNE A W. Endometriosis: Etiology, pathobiology, and therapeutic prospects[J]. Cell, 2021, 184(11): 2807-2824. doi: 10.1016/j.cell.2021.04.041
    [2]
    AGARWAL S K, CHAPRON C, GIUDICE L C, et al. Clinical diagnosis of endometriosis: a call to action[J]. Am J Obstet Gynecol, 2019, 220(4): 354. e1-354. e12. doi: 10.1016/j.ajog.2018.12.039
    [3]
    TAYLOR H S, KOTLYAR A M, FLORES V A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet, 2021, 397(10276): 839-852. doi: 10.1016/S0140-6736(21)00389-5
    [4]
    HEIDEMANN L N, HARTWELL D, HEIDEMANN C H, et al. The relation between endometriosis and ovarian cancer - a review[J]. Acta Obstet Gynecol Scand, 2014, 93(1): 20-31. doi: 10.1111/aogs.12255
    [5]
    ZWEEMER A J M, FRENCH C B, MESFIN J, et al. Apoptotic bodies elicit Gas6-mediated migration of AXL-expressing tumor cells[J]. Mol Cancer Res, 2017, 15(12): 1656-1666. doi: 10.1158/1541-7786.MCR-17-0012
    [6]
    ZHU C J, WEI Y Q, WEI X W. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications[J]. Mol Cancer, 2019, 18(1): 153. doi: 10.1186/s12943-019-1090-3
    [7]
    LIU Y, QIN X Y, LU X F, et al. Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model[J]. Can J Physiol Pharmacol, 2019, 97(10): 963-970. doi: 10.1139/cjpp-2019-0156
    [8]
    刘燕. PI3K/Akt/mTOR通路和萝卜硫烷对坐骨神经子宫内膜异位症大鼠模型疼痛机制研究[D]. 济南: 山东大学, 2021.
    [9]
    刘畅. 子宫内膜异位症差异基因筛选及潜在靶标GAS6的功能验证[D]. 重庆: 重庆医科大学, 2021.
    [10]
    DAHIYA A, SEBASTIAN A, THOMAS A, et al. Endometriosis and malignancy: the intriguing relationship[J]. Int J Gynaecol Obstet, 2021, 155(1): 72-78. doi: 10.1002/ijgo.13585
    [11]
    EDIRIWEERA M K, TENNEKOON K H, SAMARAKOON S R. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance[J]. Semin Cancer Biol, 2019, 59: 147-160. doi: 10.1016/j.semcancer.2019.05.012
    [12]
    BARRA F, FERRO DESIDERI L, FERRERO S. Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis[J]. Br J Pharmacol, 2018, 175(17): 3626-3627. doi: 10.1111/bph.14391
    [13]
    HUNG S W, ZHANG R Z, TAN Z, et al. Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: a review[J]. Med Res Rev, 2021, 41(4): 2489-2564. doi: 10.1002/med.21802
    [14]
    SUN W S, MISAO R, IWAGAKI S, et al. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases, Axl and Sky, in human uterine endometrium and ovarian endometriosis[J]. Mol Hum Reprod, 2002, 8(6): 552-558. doi: 10.1093/molehr/8.6.552
    [15]
    LI M F, YE J J, ZHAO G J, et al. Gas6 attenuates lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway[J]. Int J Mol Med, 2019, 44(3): 982-994.
    [16]
    TORREALBA N, VERA R, FRAILE B, et al. TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer[J]. Aging Male, 2020, 23(5): 801-811. doi: 10.1080/13685538.2019.1597840
    [17]
    LIU Y, QIN X Y, LU X F, et al. Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model[J]. Can J Physiol Pharmacol, 2019, 97(10): 963-970. doi: 10.1139/cjpp-2019-0156
  • Related Articles

    [1]YANG Chong, LIU Xiang, CHEN Kehan, WANG Lingli. Mechanism of Bixie Fenqing Pills in improving hyperuricemia induced renal injury by regulating uric acid transporter proteins[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 1-7. DOI: 10.7619/jcmp.20241968
    [2]CHANG Ailing, ZHAI Yaran, WANG Yujin, ZHANG Jincheng, WANG Fangzhen. Effect of dapagliflozin on vascular function and renal function of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 78-82. DOI: 10.7619/jcmp.20234180
    [3]MAO Caifeng, WEI Namin, WANG Taibin, QIAO Yushan, FAN Ruijie, LI Zefa. Correlations of serum eukaryotic translation promoter 2α and activated transcription factor 4 levels with renal tissue injury and renal function in diabetic nephropathy patients[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 73-77. DOI: 10.7619/jcmp.20233794
    [4]WANG Haitong, LIU Jianliang. Mechanism of naringin on retinal microvascular endothelial cells injury based on adenosine-monophosphate-activated protein kinase/mammalian target of rapamycin pathway[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 23-28. DOI: 10.7619/jcmp.20233233
    [5]GUO Jing, LI Yunyun, LIU Sisi, SHA Ying, MA Kai, WANG Hong. Values of serum Delta-like protein 4 and cAMP response element-binding protein levels in predicting microvascular injury of patients with different stages of diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 68-72, 78. DOI: 10.7619/jcmp.20233083
    [6]ZHOU Xinglu, LU Jiancan, MENG Ying, ZHU Hongling. Effects of dapagliflozin on glucolipid metabolism and levels of renal injury markers in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 74-78. DOI: 10.7619/jcmp.20201394
    [7]XU Gang. Value of combined detection of urinary albumin-to-creatinine ratio, β2 microglobulin and retinol binding protein in early diagnosis of diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 86-89. DOI: 10.7619/jcmp.202021025
    [8]ZHANG Junfeng, LIU Shengxian, LI Jie. Value of combined detection of four indicators in diagnosis of early renal injury in elderly patients with essential hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 97-99. DOI: 10.7619/jcmp.202014026
    [9]ZHANG Qianqian, HE Ling, TENG Yulian, LV Xiaoyun. Effects of water extract of radix salviae miltiorrhizae on renal injury in rats exposed to cadmium[J]. Journal of Clinical Medicine in Practice, 2017, (5): 5-10. DOI: 10.7619/jcmp.201705002
    [10]SHE Xiaoyin, ZHANG Haibo, MU Juxiang. Early application of continuous renal replacement therapy in acute kidney injury after cardiac surgery[J]. Journal of Clinical Medicine in Practice, 2013, (21): 94-96. DOI: 10.7619/jcmp.201321026

Catalog

    Article views (200) PDF downloads (14) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return